These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21782689)

  • 1. Mechanistic approaches for mixture risk assessments-present capabilities with simple mixtures and future directions.
    Andersen ME; Dennison JE
    Environ Toxicol Pharmacol; 2004 Mar; 16(1-2):1-11. PubMed ID: 21782689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a neurotoxic equivalence scheme of relative potency for assessing the risk of PCB mixtures.
    Simon T; Britt JK; James RC
    Regul Toxicol Pharmacol; 2007 Jul; 48(2):148-70. PubMed ID: 17475378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical mixture toxicology: from descriptive to mechanistic, and going on to in silico toxicology.
    Yang RS; El-Masri HA; Thomas RS; Dobrev ID; Dennison JE; Bae DS; Campain JA; Liao KH; Reisfeld B; Andersen ME; Mumtaz M
    Environ Toxicol Pharmacol; 2004 Nov; 18(2):65-81. PubMed ID: 21782736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polychlorinated biphenyls (PCBs): environmental impact, biochemical and toxic responses, and implications for risk assessment.
    Safe SH
    Crit Rev Toxicol; 1994; 24(2):87-149. PubMed ID: 8037844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicology of chemical mixtures: a challenging quest along empirical sciences.
    Groten JP; Heijne WH; Stierum RH; Freidig AP; Feron VJ
    Environ Toxicol Pharmacol; 2004 Dec; 18(3):185-92. PubMed ID: 21782748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,3',4,4',5-pentachlorobiphenyl (PCB 118) (Cas No. 31508-00-6) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Nov; (531):1-218. PubMed ID: 17342196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The application of physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) modeling for exploring risk assessment approaches of chemical mixtures.
    Yang RS; el-Masri HA; Thomas RS; Constan AA; Tessari JD
    Toxicol Lett; 1995 Sep; 79(1-3):193-200. PubMed ID: 7570656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the potential impact of benchmark dose and pharmacokinetic modeling in noncancer risk assessment.
    Clewell HJ; Gentry PR; Gearhart JM
    J Toxicol Environ Health; 1997 Dec; 52(6):475-515. PubMed ID: 9397182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of potential toxicity from co-exposure to three CNS depressants (toluene, ethylbenzene, and xylene) under resting and working conditions using PBPK modeling.
    Dennison JE; Bigelow PL; Mumtaz MM; Andersen ME; Dobrev ID; Yang RS
    J Occup Environ Hyg; 2005 Mar; 2(3):127-35. PubMed ID: 15764536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated approaches for the analysis of toxicologic interactions of chemical mixtures.
    el-Masri HA; Reardon KF; Yang RS
    Crit Rev Toxicol; 1997 Mar; 27(2):175-97. PubMed ID: 9099518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mode of action as a determining factor in additivity models for chemical mixture risk assessment.
    Lambert JC; Lipscomb JC
    Regul Toxicol Pharmacol; 2007 Dec; 49(3):183-94. PubMed ID: 17804132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions in the tumor-promoting activity of carbon tetrachloride, trichloroacetate, and dichloroacetate in the liver of male B6C3F1 mice.
    Bull RJ; Sasser LB; Lei XC
    Toxicology; 2004 Jul; 199(2-3):169-83. PubMed ID: 15147791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PBPK modeling of complex hydrocarbon mixtures: gasoline.
    Dennison JE; Andersen ME; Dobrev ID; Mumtaz MM; Yang RS
    Environ Toxicol Pharmacol; 2004 Mar; 16(1-2):107-19. PubMed ID: 21782697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the interaction of phytoestrogens and synthetic chemicals: an in vitro/in vivo comparison.
    Charles GD; Gennings C; Tornesi B; Kan HL; Zacharewski TR; Bhaskar Gollapudi B; Carney EW
    Toxicol Appl Pharmacol; 2007 Feb; 218(3):280-8. PubMed ID: 17222880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can mode of action predict mixture toxicity for risk assessment?
    Borgert CJ; Quill TF; McCarty LS; Mason AM
    Toxicol Appl Pharmacol; 2004 Dec; 201(2):85-96. PubMed ID: 15541748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing uncertainty in risk assessment by using specific knowledge to replace default options.
    McClellan RO
    Drug Metab Rev; 1996; 28(1-2):149-79. PubMed ID: 8744594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating pharmacokinetic and pharmacodynamic interactions with computational models in supporting cumulative risk assessment.
    Tan YM; Clewell H; Campbell J; Andersen M
    Int J Environ Res Public Health; 2011 May; 8(5):1613-30. PubMed ID: 21655141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the risks of exposures to multiple chemicals with a common mechanism of toxicity: how to cumulate?
    Wilkinson CF; Christoph GR; Julien E; Kelley JM; Kronenberg J; McCarthy J; Reiss R
    Regul Toxicol Pharmacol; 2000 Feb; 31(1):30-43. PubMed ID: 10715222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.